These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

307 related articles for article (PubMed ID: 37454017)

  • 21. Breast Implant-Associated Anaplastic Large Cell Lymphoma With Invasive Chest Wall Masses.
    Coombs DM; Aliotta R; Jagadeesh D; Raymond D; Isakov R
    Ann Plast Surg; 2021 Oct; 87(4):409-414. PubMed ID: 34176904
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinical recommendations for diagnosis and treatment according to current updated knowledge on BIA-ALCL.
    Longo B; Di Napoli A; Curigliano G; Veronesi P; Pileri S; Martelli M; De Vita R; Felici N; Cirillo P; Bernardi C; D'orsi G; Giacalone M; Storti G; Cervelli V
    Breast; 2022 Dec; 66():332-341. PubMed ID: 36502569
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Breast Implant-Associated Anaplastic Large-Cell Lymphoma: Updated Systematic Review and Analysis of Treatment Strategies.
    Naga HI; Mellia JA; Basta MN; Morris MP; Christopher AN; Campbell FM; Sommers K; Levinson H; Nelson JA; Fischer JP
    Plast Reconstr Surg; 2022 Oct; 150(4):762-769. PubMed ID: 35862104
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Breast implant-associated ALK-negative anaplastic large cell lymphoma: a case report and discussion of possible pathogenesis.
    George EV; Pharm J; Houston C; Al-Quran S; Brian G; Dong H; Hai W; Reeves W; Yang LJ
    Int J Clin Exp Pathol; 2013; 6(8):1631-42. PubMed ID: 23923082
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Differences in Human Leukocyte Antigen Expression Between Breast Implant-Associated Anaplastic Large Cell Lymphoma Patients and the General Population.
    Tevis SE; Hunt KK; Miranda RN; Lange C; Butler CE; Clemens MW
    Aesthet Surg J; 2019 Sep; 39(10):1065-1070. PubMed ID: 30715139
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinical Manifestations and Surgical Management of Breast Implant-Associated Anaplastic Large Cell Lymphoma: Beyond the NCCN Guidelines.
    Lillemoe HA; Miranda RN; Nastoupil LJ; Clemens MW; Hunt KK
    Ann Surg Oncol; 2022 Sep; 29(9):5722-5729. PubMed ID: 35597841
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Spontaneous Regression and Resolution of Breast Implant-Associated Anaplastic Large Cell Lymphoma: Implications for Research, Diagnosis and Clinical Management.
    Fleming D; Stone J; Tansley P
    Aesthetic Plast Surg; 2018 Jun; 42(3):672-678. PubMed ID: 29445921
    [TBL] [Abstract][Full Text] [Related]  

  • 28. UK Guidelines on the Diagnosis and Treatment of Breast Implant-Associated Anaplastic Large Cell Lymphoma (BIA-ALCL) on behalf of the Medicines and Healthcare products Regulatory Agency (MHRA) Plastic, Reconstructive and Aesthetic Surgery Expert Advisory Group (PRASEAG).
    Turton P; El-Sharkawi D; Lyburn I; Sharma B; Mahalingam P; Turner SD; MacNeill F; Johnson L; Hamilton S; Burton C; Mercer N
    Eur J Surg Oncol; 2021 Feb; 47(2):199-210. PubMed ID: 33358076
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Breast Implant-associated Anaplastic Large Cell Lymphoma.
    Alotaibi S; Hamadani M; Al-Mansour M; Aljurf M
    Clin Lymphoma Myeloma Leuk; 2021 Mar; 21(3):e272-e276. PubMed ID: 33384263
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Epidemiological Profile in Portugal of Breast Implant-Associated Anaplastic Large Cell Lymphoma: A Cross-Sectional Study.
    Cunha A; Horta R; Barreiro D
    Acta Med Port; 2021 Aug; 34(9):572-579. PubMed ID: 33512315
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Public Perceptions on Breast Implant-Associated Anaplastic Large Cell Lymphoma.
    Lee E; Khavanin N; He W; Darrach H; Kraenzlin F; Jenny H; Yang R; Sacks JM
    Plast Reconstr Surg; 2020 Jul; 146(1):30-37. PubMed ID: 32590638
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cost and clinical benefit of imaging surveillance after treatment for breast implant-associated anaplastic large cell lymphoma (BIA-ALCL).
    O'Connell RL; Sharma B; Van Kerckhoven L; Mehdi AS; Marshall C; Wotherspoon A; Iyengar S; El-Sharkawi D; Attygalle AD; Jurgensen-Rauch A; Cunningham D; MacNeill F; Khan AA; Tasoulis MK
    Eur J Surg Oncol; 2022 Apr; 48(4):748-751. PubMed ID: 34974948
    [TBL] [Abstract][Full Text] [Related]  

  • 33. En Bloc Capsulectomy for Breast Implant Illness: A Social Media Phenomenon?
    Keane G; Chi D; Ha AY; Myckatyn TM
    Aesthet Surg J; 2021 Mar; 41(4):448-459. PubMed ID: 32940709
    [TBL] [Abstract][Full Text] [Related]  

  • 34. BIA-ALCL and Textured Breast Implants: A Systematic Review of Evidence Supporting Surgical Risk Management Strategies.
    Nelson JA; McCarthy C; Dabic S; Polanco T; Chilov M; Mehrara BJ; Disa JJ
    Plast Reconstr Surg; 2021 May; 147(5S):7S-13S. PubMed ID: 33890875
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Ruptured breast implant removal because of patient anxiety in the absence of breast implant-associated anaplastic large cell lymphoma.
    Takahashi H; Sato H; Tsunekawa Y; Fujioka U; Wanifuchi-Endo Y; Toyama T; Toriyama K
    Nagoya J Med Sci; 2023 Nov; 85(4):852-856. PubMed ID: 38155618
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Breast Implant-Associated Anaplastic Large-Cell Lymphoma in Brazil: What Are We Missing?
    Groth AK; Clemens MW; Graf R; Sebastião AP; Azambuja AP; Louveira MH; Urban LABD; Batista BN
    Plast Reconstr Surg; 2022 Nov; 150(5):970e-978e. PubMed ID: 35994334
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Is Banning Texturized Implants to Prevent Breast Implant-Associated Anaplastic Large Cell Lymphoma a Rational Decision? A Meta-Analysis and Cost-Effectiveness Study.
    Danilla SV; Jara RP; Miranda F; Bencina F; Aguirre M; Troncoso E; Erazo CA; Andrades PR; Sepulveda SL; Albornoz CR
    Aesthet Surg J; 2020 Jun; 40(7):721-731. PubMed ID: 31761953
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Implications of Breast Implant-Associated Anaplastic Large Cell Lymphoma (BIA-ALCL) for Breast Cancer Reconstruction: An Update for Surgical Oncologists.
    O'Neill AC; Zhong T; Hofer SOP
    Ann Surg Oncol; 2017 Oct; 24(11):3174-3179. PubMed ID: 28762113
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Spontaneous Regression and Resolution of Breast Implant-Associated Anaplastic Large Cell Lymphoma: Implications for Research, Diagnosis and Clinical Management.
    Fleming D; Stone J; Tansley P
    Aesthetic Plast Surg; 2020 Aug; 44(4):1109-1115. PubMed ID: 32766915
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Breast Implant-associated Anaplastic Large Cell Lymphoma Incidence: Determining an Accurate Risk.
    Nelson JA; Dabic S; Mehrara BJ; Cordeiro PG; Disa JJ; Pusic AL; Matros E; Dayan JH; Allen RJ; Coriddi M; Polanco TO; Shamsunder MG; Wiser I; Morrow M; Dogan A; Cavalli MR; Encarnacion E; Lee ME; McCarthy CM
    Ann Surg; 2020 Sep; 272(3):403-409. PubMed ID: 32694446
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.